Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima

Podsumowanie

Mitophagy, the selective degradation of mitochondria, has been implicated in mitochondrial homeostasis and is deregulated in various human diseases. However, convenient experimental methods for measuring mitophagy activity are very limited. Here, we provide a sensitive assay for measuring mitophagy activity using flow cytometry.

Streszczenie

Mitophagy is a process of selective removal of damaged or unnecessary mitochondria using autophagy machinery. Close links have been found between defective mitophagy and various human diseases, including neurodegenerative diseases, cancer, and metabolic diseases. In addition, recent studies have shown that mitophagy is involved in normal cellular processes, such as differentiation and development. However, the precise role of and molecular mechanisms underlying mitophagy require further study. Therefore, it is critical to develop a robust and convenient method for measuring changes in mitophagy activity. Here, we describe a detailed protocol for quantitatively assessing mitophagy activity through flow cytometry using the mitochondria-targeted fluorescent protein Keima (mt-Keima). This flow cytometry assay can analyze mitophagy activity more rapidly and sensitively than conventional microscopy- or immunoblotting-based methods. This protocol can be applied to analyze mitophagy activity in various cell types.

Wprowadzenie

Mitochondria are organelles that are essential for cell proliferation and physiology. Mitochondria are responsible for generating more than 80% of the ATP supply via oxidative phosphorylation, and they also provide various metabolic intermediates for biosynthesis and metabolism^1,2. In addition to their roles in energy supply and metabolism, mitochondria play central roles in many other important processes, including reactive oxygen species (ROS) generation, the regulation of cell death, and intracellular Ca²⁺ dynamics³. Alterations in mitochondrial function have been associated with human diseases, including cancer, diabetes mellitus and various neurodegenerative diseases^4,5. Increased mitochondrial dysfunction and mitochondrial DNA mutations are also thought to contribute to normal aging processes^6,7,8. Therefore, quality control is a crucial issue in mitochondria. Mitochondria are highly dynamic organelles that can continuously change their shape between elongated networks and short, fragmented form. Mitochondria dynamics plays an important role in maintaining the function of mitochondria as well as their degradation through mitophagy⁹.

Mitophagy is a mechanism that involves the selective degradation of whole mitochondria using the autophagy machinery. Mitophagy is the principle mechanism underlying mitochondrial turnover and the removal of damaged or dysfunctional mitochondria. In this process, mitochondria are first surrounded by a membrane, resulting in the formation of autophagosomes, which then fuse with lysosomes for hydrolytic degradation⁹. Previous genetic studies in Drosophila have suggested that two Parkinson's disease-related genes, PTEN-induced putative kinase 1 (PINK1) (PARK6) and Parkin (PARK2), function in the same pathway^10,11. Subsequence studies have shown that the PINK1-Parkin pathway is responsible for eliminating damaged mitochondria and defects in this pathway result in dysfunctional mitophagy and may contribute to human diseases^12,13. Defects in mitophagy processes have recently been found in various human diseases, including cancer, heart disease, liver diseases and neurodegenerative disease ¹⁴. In addition, recent studies have also shown that mitophagy is critical to many physiological processes, such as differentiation, development, and the immune response^{15,16,17,18,19}, suggesting that mitophagy may play a more active role in controlling cell functions.

Despite recent confirmation that mitophagy plays an important role in both quality control in mitochondria and human disease, the molecular mechanisms underlying mitophagy remain poorly understood. Although mitophagy-related mechanisms have been systematically studied in yeast, studies aimed at exploring mitophagy-related mechanisms in mammalian cells have mainly focused on the PINK1-Parkin pathway. Previous studies have established that the PINK1-Parkin pathway is primarily responsible for the selective removal of damaged mitochondria via mitophagy^12,20,21. However, recent studies have reported that in some models, mitophagy can be activated even in the absence of functional PINK1^22,23,24. These results suggest that in addition to the PINK1-Parkin pathway, there an additional unidentified pathway that can activate mitophagy.

The absence of a convenient method to assess mitophagy activity is a major obstacle to exploring the pathways that regulate mitophagy and its role in pathophysiological events. Electron microscopy is a powerful tool to directly visualize autophagosome-engulfed mitochondria. However, electron microscopy has limitations in quantifying mitophagy activity. Although strategies that use microtubule-associated protein-1 light chain 3 (LC3)-conjugated fluorescent probes, such as GFP-LC3, are currently the most widely used approaches²⁵, the transient nature of the LC3-based signal and its high rate of false-positive signals limit its sensitivity for detecting mitophagy in cells²⁶. A combination of western blotting to measure mitochondrial protein level, the quantification of mitochondrial DNA, and fluorescence microscopy analysis to colocalize mitochondria with either autophagosomes or lysosomes would be a good approach for assessing mitophagy. However, quantification limitations and a lack of convenience of existing methodologies call for new approaches. The introduction of a new pH-dependent fluorescent protein, the mitochondrial target Keima (mt-Keima), greatly improved the ability to detect mitophagy²⁷. By fusing the mitochondrial-targeting sequence of cytochrome c oxidase subunit VIII (COX VIII) into Keima, mt-Keima is directed to the mitochondrial matrix. The large shift in the excitation peak of Keima from 440 nm to 586 nm (corresponding to pH 7 and pH 4, respectively) can be utilized to assess mitophagy with good sensitively in both in vitro and in vivo experiments^28,29. More importantly, the resistance of mt-Keima to lysosomal degradation causes the integration of the mt-Keima signal in lysosomes, allowing for the easy quantitative measurement of mitophagy activity. The fluorescence change that occurs in mt-Keima can be analyzed using either confocal microscopy or flow cytometry^28,29. However, a flow cytometry-based method for measuring mitophagy activity using mt-Keima has not been provided in detail to date.

Here, we describe a detailed protocol for a flow cytometry-based technique for measuring mitophagy activity in cells using mt-Keima. Although we have shown here that flow cytometry analysis successfully detected CCCP-induced mitophagy in HeLa cells expressing Parkin, this technique can be applied to a wide variety of cell types.

Access restricted. Please log in or start a trial to view this content.

Protokół

1. Generation of HeLa cells expressing mito-Keima (mt-Keima)

1. Preparation of mt-Keima lentivirus
   1. Coat a 100-mm culture dish by adding 2 mL of 0.001% poly-L-lysine/phosphate-buffered saline (PBS) and allow it to stand for 5 min at room temperature.
   2. Remove the poly-L-lysine solution using a glass pipette connected to a vacuum and wash the culture dish by adding 2 mL of 1x PBS.
   3. Plate 1.5 x 10⁶ HEK293T cells on the coated culture dish with 10 mL of DMEM containing 10% FBS and 1% penicillin/streptomycin, and culture the cells at 37 °C in a CO₂ tissue culture incubator for one day.
   4. Transfect 2 µg of mt-Keima lentiviral plasmid²⁹ DNA together with packaging DNAs (psPAX 2 µg and pVSVG 0.25 µg) using a transfection reagent for 8 h according to the manufacturer's instructions.
   5. Remove the transfection media and add 8 mL of fresh media.
   6. Collect the media containing viral particles 48 h later. Remove cellular debris from the collected media by centrifugation at 500 x g for 5 min and filter them with a 0.45-µm syringe filter.
      Note: For long-term use, make aliquots of lentiviral particles and store the samples at -80 °C. Avoid subjecting the viral samples to freeze-thaw cycles for efficient viral infection.
2. Infecting HeLa-Parkin cells with mt-Keima lentivirus
   1. Plate 5 x 10⁴ HeLa cells expressing Parkin (HeLa-Parkin) in a 60-mm culture dish with 4 mL of DMEM containing 10% FBS and 1% penicillin/streptomycin at 37 °C one day before harvesting the mt-Keima lentivirus.
      Note: Because of the absence of endogenous Parkin expression in HeLa cells³⁰, the HeLa-Parkin cells used here to more clearly show CCCP-induced mitophagy. This procedure can also be applied to other primary or immortalized cell lines.
   2. Remove the growth medium the next day and add 1 mL of mt-Keima lentiviral media. Add an additional 2 mL of growth medium containing 3 µL of polybrene stock solution (8 mg/mL in distilled water). Incubate for one day in a CO₂ tissue culture incubator.
   3. Remove the mt-Keima lentiviral mixture the next day and wash the cells twice with 1x PBS. Add 4 mL of growth medium and treat the cells with 2 µg/mL puromycin for two days.
   4. After two days of puromycin selection, remove the growth medium, and wash the cells twice with 1x PBS. Add growth medium, and culture the cells in a CO₂ incubator until use.
      Note: This method can be applied to generate cells that stably express mt-Keima, including other cell lines and primary cells.

2. Inducing mitophagy using CCCP treatment and preparing FACS samples

1. Plate 5 x 10⁴ HeLa-Parkin cells expressing mt-Keima in a 60-mm culture dish with 4 mL of DMEM containing 10% FBS and 1% penicillin/streptomycin and culture them for one day at 37 °C in a CO₂ tissue culture incubator.
2. Remove the growth medium the next day and add 4 mL of fresh DMEM containing 10 µM carbonyl cyanide m-chlorophenylhydrazone (CCCP). Incubate HeLa-Parkin-mt-Keima cells in a CO₂ tissue incubator for 6 h.
3. Remove the growth medium 6 h later and wash the cells with 2 mL of 1x PBS. Detach the cells by treating them with trypsin/EDTA solution and inactivate the trypsin by adding growth medium containing 10% FBS. Transfer the cells into a 15-mL conical tube.
4. Centrifuge the cells at 500 x g for 5 min.
5. Carefully remove the growth medium by aspiration and resuspend the cells with 1 mL of cold 1x PBS.
6. Transfer cells into the appropriate FACS tube and place it on ice.
   Note: Prepare uninfected HeLa cells as a negative control.
   Note: Cells are viable on ice for several hours, and mt-Keima fluorescence signals also remain stable.

3. FACS analysis of mitophagy

Note: In this study, cells were analyzed with a flow cytometer equipped with a 405-nm and 561-nm laser. Cells were excited with a violet laser (405 nm) with emission detected at 610 ± 10 nm with a BV605 detector and with a yellow-green laser (561 nm) with emission detected at 610 ± 10 nm by a PE-CF594 detector simultaneously (Figure 1).

1. Gating live cells
   1. Turn on the flow cytometer and computer and log into the analysis software.
   2. Generate a new experiment or duplicate an existing experiment. To excite cells with the violet (405 nm) and yellow-green (561 nm) lasers and detect emission at 610 ± 10 nm detector, select BV605 and PE-CF594 in addition to forward scatter (FSC) and side scatter (SSC) in the parameter window as required fluorophores.
      Note: All fluorophores should be added in a linear mode.
   3. Vortex each cell sample briefly to disperse cell aggregates.
   4. Place the tube containing a control HeLa-Parkin cell sample that is not infected with mt-Keima lentivirus on the sample injection port and press the "run" button on the cytometer.
   5. In the dot plot of FSC versus SSC, adjust the FSC and SSC voltage to place cells in the center of the dot plot.
   6. Draw a P1 gate using the Polygon icon around live cells and eliminate dead cells and cell debris (Figure 2A).
2. Adjust voltages for violet and green laser
   1. Place the tube containing HeLa-Parkin cells infected with mt-Keima lentivirus on the sample injection port and press the "run" button on the cytometer.
   2. In the dot plot of BV605 (405 nm) versus SSC, adjust the BV605 voltage so that HeLa-Parkin cells expressing mt-Keima are clearly distinguished from control cells that do not express mt-Keima (Figure 2B).
   3. In the dot plot of PE-CF594 (561 nm) versus SSC, adjust the PE-CF594 voltage so that HeLa-Parkin cells expressing mt-Keima are clearly distinguished from control cells (Figure 2B).
3. Assess the percentage of cells in mitophagy
   1. Acquire the BV605 versus PE-CF594 dot plot using a linear scale. Draw a gate using the Polygon icon around cells expressing mt-Keima, and eliminate cells not expressing mt-Keima (Figure 3A). The mt-Keima fluorescence-positive cell population is referred to as the "mt-Keima" gate.
   2. Create another dot plot of BV605 versus PE-CF594 showing only "mt-Keima"-gated cells. In this dot plot, draw a gate around untreated mt-Keima-positive cells. The basal mitophagy activity of control HeLa cells is low, and the ratio of emission at PE-CF594/BV605 is less than 1. Thus, this gate is referred to as the "low" gate.
   3. Draw another gate containing the above region of the "low" gate. This gate is referred to as the "high" gate because it contains cells with high mitophagy activity, that is, cells with a high ratio of emission at PE-CF594/BV605 (Figure 3B).
   4. To calculate the percentage of cells in the "high" gate, select the "Show Population Hierarchy" menu. The "Percent of Parent" (%Parent) value represents the percentage of cells in the "high" gate among the mt-Keima-positive population.
   5. Set at least 10,000 events to record in the "mt-Keima" stopping gate and run each sample.

Access restricted. Please log in or start a trial to view this content.

Wyniki

An example of the flow cytometry analysis of CCCP-induced mitophagy in HeLa-Parkin cells is shown in Figure 4. Using the flow cytometry analysis method described above, we can detect a dramatic increase in mitophagic cells in the "high" gate. The percentage of cells in the "high" gate was increased more than 10-fold compared with untreated control cells (Figure 4A). This increase in mitophagy activity was complete...

Access restricted. Please log in or start a trial to view this content.

Dyskusje

Here, we present a rapid and sensitive method for using flow cytometry to measure cellular mitophagy activity in cells expressing mt-Keima. Cells undergoing a high level of mitophagy exhibit an increased ratio of PE-CF594 (561 nm)/BV605 (405 nm) excitation. Thus, mitophagy activity can be expressed as the percentage of cells exhibiting a high 561/405 ratio. We calculated the percentage of cells in the "high" gate region on a dot plot of PE-CF594 (561 nm) versus BV605 (405 nm), and the results showed that treatmen...

Access restricted. Please log in or start a trial to view this content.

Materiały

Name	Company	Catalog Number	Comments
REAGENTS
poly-L-lysine	Sigma-Aldrich	P2636
FBS	GIBCO	16000-044
penicillin/streptomycin	wellgene	LS202-02
PBS	Hyclone	SH30013.02
HEK293T	ATCC	CRL-3216
DMEM	GIBCO	12800-082
OPTI-MEM	GIBCO	31985-070
Turbofect	Thermos scientific	R0531
0.45 μm syringe filter	sartorius	16555
HeLa	ATCC	CCL-2
polybrene	Sigma-Aldrich	H9268	8 mg/ml
puromycin	Sigma-Aldrich	P8833	2 mg/ml
Carbonyl cyanide m-chlorophenyl hydrazine (CCCP)	Sigma-Aldrich	C2759	10 mM
trypsin-EDTA	wellgene	LS015-01
EQUIPMENTS
BD LSRFortessa	BD Bioscience	LSRFortessa
FACSDIVA	BD Bioscience	FACSDIVA (v8.0.1)